Overview

Pharmacokinetics of Two Different Formulation of Voriconazole

Status:
Completed
Trial end date:
2016-08-01
Target enrollment:
Participant gender:
Summary
A Randomized, Parallel, Single-Dose Study to Evaluate the Pharmacokinetics of Two Different Formulation of Voriconazole 200 mg Tablets in Healthy Adult Subjects.
Phase:
Phase 4
Details
Lead Sponsor:
Yung Shin Pharm. Ind. Co., Ltd.
Collaborator:
Taichung Veterans General Hospital
Treatments:
Voriconazole